These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 1304463)
1. Prospective double-blind study of CEE3 in peri- and postmenopausal women: effects on bone loss and lipoprotein lipids. Cheng GJ; Liu JL; Zhang Q; Ye HF; Wang ZQ; Pan HP Chin Med J (Engl); 1992 Nov; 105(11):929-33. PubMed ID: 1304463 [TBL] [Abstract][Full Text] [Related]
2. [A prospective study of nylestriol on plasma lipids in postmenopausal women]. Cheng GJ Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):349-51, 387-8. PubMed ID: 1804605 [TBL] [Abstract][Full Text] [Related]
3. Nylestriol replacement therapy in postmenopausal women. A three-year prospective study. Cheng GJ; Liu JL; Zhang Q; Fan W; Ye HF; Wang ZQ; Pan HP Chin Med J (Engl); 1993 Dec; 106(12):911-6. PubMed ID: 8198628 [TBL] [Abstract][Full Text] [Related]
4. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449 [TBL] [Abstract][Full Text] [Related]
5. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial. Bunyavejchevin S; Limpaphayom KK J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499 [TBL] [Abstract][Full Text] [Related]
6. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women. Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213 [TBL] [Abstract][Full Text] [Related]
7. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women. Zegura B; Guzic-Salobir B; Sebestjen M; Keber I Menopause; 2006; 13(4):643-50. PubMed ID: 16837886 [TBL] [Abstract][Full Text] [Related]
8. [The effects of progestin on the bone metabolism in postmenopausal women]. Ren Y; Zhu G Zhonghua Fu Chan Ke Za Zhi; 1995 Mar; 30(3):135-7. PubMed ID: 7796643 [TBL] [Abstract][Full Text] [Related]
9. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium. Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899 [TBL] [Abstract][Full Text] [Related]
10. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW Menopause; 2003; 10(4):337-44. PubMed ID: 12851517 [TBL] [Abstract][Full Text] [Related]
11. [Effect of nylestriol on postmenopausal uterine endometrium]. Liu JL Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):76-8, 122. PubMed ID: 8344085 [TBL] [Abstract][Full Text] [Related]
12. [Prospective study on nylestriol replacement therapy in postmenopausal women]. Cheng GJ Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):534-8, 569. PubMed ID: 8313746 [TBL] [Abstract][Full Text] [Related]
13. [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies]. Blumel JE; Brandt A; Garabagno A; Cubillos M; Lozano A Rev Med Chil; 1990 Apr; 118(4):382-7. PubMed ID: 2133147 [TBL] [Abstract][Full Text] [Related]
14. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women. Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528 [TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Ho SC; Chen YM; Ho SS; Woo JL Menopause; 2007; 14(5):905-12. PubMed ID: 17413839 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy. Luciano AA; De Souza MJ; Roy MP; Schoenfeld MJ; Nulsen JC; Halvorson CV J Reprod Med; 1993 Mar; 38(3):207-14. PubMed ID: 8487239 [TBL] [Abstract][Full Text] [Related]
17. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis]. Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505 [TBL] [Abstract][Full Text] [Related]
18. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women. Barnes RB; Roy S; Lobo RA Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832 [TBL] [Abstract][Full Text] [Related]
19. Effects of oral and transdermal hormone replacement therapy on lipoprotein(A) and lipids: a randomized controlled trial. Meschia M; Bruschi F; Soma M; Amicarelli F; Paoletti R; Crosignani P Menopause; 1998; 5(3):157-62. PubMed ID: 9774761 [TBL] [Abstract][Full Text] [Related]
20. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins. Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]